GLP-1 drugs , or glucagon-like peptide-1 receptor agonists , represent a remarkable development in how we approach diabetes mellitus . These new drugs function to stimulating the body’s own GLP-1 https://bookmark-search.com/story21608189/glp-1-a-major-advance-in-diabetes-care